This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Ellen Santangelo: Innovator in Dihydropyridopyrimidine Compounds
Introduction
Ellen Santangelo is a notable inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating AB-related pathologies. Her work exemplifies the intersection of innovation and healthcare.
Latest Patents
Ellen holds a patent for "Dihydropyridopyrimidines for the treatment of AB-related pathologies." This patent includes dihydropyridopyrimidine compounds of formula (Ia) and therapeutically acceptable salts thereof. The compounds are defined by specific parameters, with processes for making them and methods for using them in the treatment of Aβ-related pathologies.
Career Highlights
Ellen is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves research and development, focusing on innovative solutions for complex medical challenges. With her expertise, she contributes to advancing therapeutic options for patients.
Collaborations
Ellen has collaborated with esteemed colleagues, including Rickard Forsblom and Didier Rotticci. These partnerships enhance the research environment and foster innovative approaches to drug development.
Conclusion
Ellen Santangelo's work in the field of dihydropyridopyrimidine compounds showcases her dedication to improving healthcare through innovation. Her contributions are vital in the ongoing quest for effective treatments for AB-related pathologies.